A Primer on Clinical Trials for Patients With Gaucher Disease and Other Rare Illnesses
mcmurryjulie / Pixabay

A Primer on Clinical Trials for Patients With Gaucher Disease and Other Rare Illnesses

According to a post from gaucherdisease.org, clinical trials are an essential component to the development and testing of new therapies for Gaucher disease and other rare diseases. For some rare…

Continue Reading A Primer on Clinical Trials for Patients With Gaucher Disease and Other Rare Illnesses

In Honor of Tay-Sachs Disease Awareness Month Organizations are Teaming Together to Spread Awareness of Genetic Testing

Tay-Sachs Disease September is Tay-Sachs Disease Awareness Month. Voted on by the Senate unanimously in 2008, this month aims to spread awareness about this disease and the importance of carrier…

Continue Reading In Honor of Tay-Sachs Disease Awareness Month Organizations are Teaming Together to Spread Awareness of Genetic Testing
Study to Test Possible Biomarker for Myopathy Associated With Mitochondrial Disease
argzombies / Pixabay

Study to Test Possible Biomarker for Myopathy Associated With Mitochondrial Disease

According to a story from clinicaltrials.gov, the Children's Hospital of Philadelphia is sponsoring a study that has the potential to make mitochondrial disease research and drug development much easier. The…

Continue Reading Study to Test Possible Biomarker for Myopathy Associated With Mitochondrial Disease
Michigan Researchers to Study Neurofilament Light Chain Blood Levels as a Predictor of Multiple Sclerosis
source: pixabay.com

Michigan Researchers to Study Neurofilament Light Chain Blood Levels as a Predictor of Multiple Sclerosis

According to a publication from BioSpace, researchers from Michigan's Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis are taking full advantage of recent technological advances in neurofilament light chain testing…

Continue Reading Michigan Researchers to Study Neurofilament Light Chain Blood Levels as a Predictor of Multiple Sclerosis
Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs
qimono / Pixabay

Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs

According to a story from sectorpublishingintelligence.co.uk, studies utilizing data gathered in the real-world treatment setting are highlighting the characteristics of two different therapies for multiple sclerosis (MS) developed by the…

Continue Reading Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs
Eosinophilic Esophagitis Patients at High Risk of Relapse After Stopping Treatment, Study Says
jarmoluk / Pixabay

Eosinophilic Esophagitis Patients at High Risk of Relapse After Stopping Treatment, Study Says

According to a story from Healio, the results of a randomized trial suggest that patients with eosinophilic esophagitis are likely to experience rapid relapse if they stop treatment. This was…

Continue Reading Eosinophilic Esophagitis Patients at High Risk of Relapse After Stopping Treatment, Study Says
Infant With Juvenile Myelomonocytic Leukemia Successfully Treated With Liver Cancer Drug
Pexels / Pixabay

Infant With Juvenile Myelomonocytic Leukemia Successfully Treated With Liver Cancer Drug

According to a story from Science Daily, the University of California San Francisco's Benioff Children's Hospitals have successfully treated an infant with juvenile myelomonocytic leukemia. The drug used for treatment…

Continue Reading Infant With Juvenile Myelomonocytic Leukemia Successfully Treated With Liver Cancer Drug
Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says
Free-Photos / Pixabay

Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says

According to a story from Medscape, a recent study is highlighting the fact that many thyroid cancer survivors are still worried about cancer-related problems years after the conclusion of treatment.…

Continue Reading Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says
Scientists Are Using Pigs to Develop a More Useful Animal Model of Neurofibromatosis Type 1
RoyBuri / Pixabay

Scientists Are Using Pigs to Develop a More Useful Animal Model of Neurofibromatosis Type 1

According to a story from wearegreenbay.com, a team of scientists associated with the University of Wisconsin, Madison are undertaking a project that will help improve the effectiveness of research related…

Continue Reading Scientists Are Using Pigs to Develop a More Useful Animal Model of Neurofibromatosis Type 1
Grant From The American Neuromuscular Foundation Will Focus on Chronic Inflammatory Demyelinating Polyneuropathy
mwooten / Pixabay

Grant From The American Neuromuscular Foundation Will Focus on Chronic Inflammatory Demyelinating Polyneuropathy

According to a story from newswise.com, the American Neuromuscular Foundation has recently awarded a grant to Dr. Karissa Gable. This grant will go towards a research project headed by Dr.…

Continue Reading Grant From The American Neuromuscular Foundation Will Focus on Chronic Inflammatory Demyelinating Polyneuropathy
New Study Will Investigate Methods to Improve Cancer Trial Participation for Historically Under-Represented Groups
truthseeker08 / Pixabay

New Study Will Investigate Methods to Improve Cancer Trial Participation for Historically Under-Represented Groups

According to a story from journals.lww.com, The Lazarex Cancer Foundation and the University of California San Francisco have announced plans to work together on a three year study that will…

Continue Reading New Study Will Investigate Methods to Improve Cancer Trial Participation for Historically Under-Represented Groups

An Experimental Drug Could be Effective for Neuromyelitis Optica, Study Results Show

According to a story from Biotech 365, the biotechnology company Viela Bio announced the publication of critical results from a recent study that tested the company's investigational drug inebilizumab as…

Continue Reading An Experimental Drug Could be Effective for Neuromyelitis Optica, Study Results Show